1. Home
  2. ODTX vs NN Comparison

ODTX vs NN Comparison

Compare ODTX & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo NextNav Inc.

NN

NextNav Inc.

N/A

Current Price

$7.81

Market Cap

1.5B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ODTX
NN
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
ODTX
NN
Price
$16.85
$7.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
3
Target Price
★ $34.67
$33.67
AVG Volume (30 Days)
291.0K
★ 3.4M
Earning Date
11-04-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $4,573,000.00
Revenue This Year
N/A
$9.63
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$15.10
$7.60
52 Week High
$29.05
$24.42

Technical Indicators

Market Signals
Indicator
ODTX
NN
Relative Strength Index (RSI) 36.09 34.48
Support Level $15.73 $7.60
Resistance Level $19.60 $17.55
Average True Range (ATR) 1.69 0.86
MACD -0.19 0.05
Stochastic Oscillator 6.10 9.89

Price Performance

Historical Comparison
ODTX
NN

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About NN NextNav Inc.

NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.

Share on Social Networks: